Leaflet NIMESULID MCC 100mg tablets

Indicated for: pain and inflammation

Route of administration: oral

Substance: nimesulide (nonsteroidal anti-inflammatory drug)

ATC: M01AX17 (Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Other antiinflammatory and antirheumatic agents, non-steroids)

Precautions:
Hepatotoxicity
Hepatotoxicity

This medicine may affect the liver.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Ulcer / gastrointestinal bleeding
Ulcer / gastrointestinal bleeding

This medicine may increase the risk of ulcer or gastrointestinal bleeding.

Nimesulide is a nonsteroidal anti-inflammatory drug (NSAID) used to treat acute pain, inflammation, and fever. It is indicated for conditions such as muscle pain, joint pain, arthritis, dysmenorrhea (menstrual pain), and other types of acute pain. Nimesulide works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, thereby reducing the production of prostaglandins, substances involved in inflammation and pain.

It is administered orally, usually in the form of tablets or granules for suspension, with a recommended dose of 100 mg twice daily, after meals, to minimize the risk of gastric irritation. The duration of treatment should be as short as possible, typically no longer than 15 days.

Common side effects include nausea, vomiting, diarrhea, abdominal pain, and dizziness. In rare cases, it may cause more serious reactions, such as liver damage, severe allergic reactions, or gastrointestinal disorders like ulcers or bleeding.

Nimesulide is contraindicated in patients with severe liver impairment, severe kidney impairment, active gastric ulcers, gastrointestinal bleeding, or hypersensitivity to the drug. It is also not recommended for children under 12 years of age, pregnant women, or breastfeeding mothers. Patients should follow their doctor's recommendations and not exceed the prescribed dose.

General data about NIMESULID MCC 100mg

  • Substance: nimesulide
  • Date of latest medicines list: 01-06-2026
  • Product code: W08886001
  • Concentration: 100mg
  • Pharmaceutical form: tablets
  • Quantity: 10
  • Product type: Generic medicine
  • Price: 5.16 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: MAGISTRA C&C S.R.L. - ROMANIA
  • Holder: MAGISTRA C&C S.R.L. - ROMANIA
  • Number: 9084/2016/01
  • Shelf life: 3 years

Pharmaceutical forms available for nimesulide

Concentrations available for nimesulide

  • 100mg
  • 30mg/g

Compensation lists for NIMESULID MCC 100mg Magistra

D - Sublist D with 20% discount from the reference price

Price

Copayment

Patient

5.16 RON

1.01 RON

4.15 RON